1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 48 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Influence of occlusion site and baseline ischemic core on outcome in patients with ischemic strokeTian, H.; Parsons, M.W.; Levi, C.R.; Lin, L.; Aviv, R.I.; Spratt, N.J.; Butcher, K.S.; Lou, M.; Kleinig, T.J.; Bivard, A.
2019Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysisChen, C.; Parsons, M.W.; Levi, C.R.; Spratt, N.J.; Miteff, F.; Lin, L.; Cheng, X.; Lou, M.; Kleinig, T.; Butcher, K.; Dong, Q.; Bivard, A.
2014Merkel cell carcinoma of the eyelid management and prognosisHerbert, H.; Sun, M.; Selva, D.; Fernando, B.; Saleh, G.; Beaconsfield, M.; Collin, R.; Uddin, J.; Meligonis, G.; Leatherbarrow, B.; Ataullah, S.; Irion, L.; McLean, C.; Huilgol, S.; Davis, G.; Sullivan, T.
2019Alpha-Blockers as colorectal cancer chemopreventive: findings from a case-control study, human cell cultures, and in vivo preclinical testingSuzuki, N.; Niikura, R.; Ihara, S.; Hikiba, Y.; Kinoshita, H.; Higashishima, N.; Hayakawa, Y.; Yamada, A.; Hirata, Y.; Nakata, R.; Okamoto, M.; Sano, M.; Kushiyama, A.; Ichinose, M.; Woods, S.L.; Worthley, D.; Iwamoto, Y.; Koike, K.
2011Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patientsRawson, J.; Manno, M.; Mrkonjic, M.; Daftary, D.; Dicks, E.; Buchanan, D.; Younghusband, H.; Parfrey, P.; Young, J.; Pollett, A.; Green, R.; Gallinger, S.; McLaughlin, J.; Knight, J.; Bapat, B.
2015Phase 2 study of intralesional PV-10 in refractory metastatic melanomaThompson, J.; Agarwala, S.; Smithers, B.; Ross, M.; Scoggins, C.; Coventry, B.; Neuhaus, S.; Minor, D.; Singer, J.; Wachter, E.
2012Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the colorectal cancer family registryLevine, A.; Win, A.; Buchanan, D.; Jenkins, M.; Baron, J.; Young, J.; Long, T.; Weisenberger, D.; Laird, P.; McCall, R.; Duggan, D.; Haile, R.
2014Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsYeung, D.; Mauro, M.
2014IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylationSmith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
2015Definition and validation of "favorable high-risk prostate cancer": implications for personalizing treatment of radiation-managed patientsMuralidhar, V.; Chen, M.; Reznor, G.; Moran, B.; Braccioforte, M.; Beard, C.; Feng, F.; Hoffman, K.; Choueiri, T.; Martin, N.; Sweeney, C.; Trinh, Q.; Nguyen, P.

Discover